← All trials
NCT04139213
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 25, 2019
- Primary completion
- Mar 25, 2022
- Completion date
- Jul 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 250
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Brown UniversityLead sponsor
- Brown UniversityCollaborator
- Rhode Island HospitalOverall official - principal investigator
- Brown UniversityReponsible party - principal investigator
- University of Rhode IslandCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.